Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
South Korea · Delayed Price · Currency is KRW 6,560.00
-80.00 (-1.20%)
At close: Mar 6, 2026
Daehan Nupharm Market Cap
Daehan Nupharm has a market cap or net worth of 92.07 billion as of March 6, 2026. Its market cap has decreased by -6.95% in one year.
Market Cap
92.07B
Enterprise Value
155.61B
Revenue
201.59B
Ranking
n/a
PE Ratio
8.46
Stock Price
6,560.00
Market Cap Chart
Since March 3, 2003, Daehan Nupharm's market cap has increased from 13.03B to 92.07B, an increase of 606.50%. That is a compound annual growth rate of 8.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 92.07B | -0.15% |
| Dec 30, 2025 | 92.21B | -4.37% |
| Dec 30, 2024 | 96.42B | -24.09% |
| Dec 28, 2023 | 127.02B | 5.97% |
| Dec 29, 2022 | 119.86B | -21.65% |
| Dec 30, 2021 | 152.98B | -13.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharos iBio | 113.15B |
| Samik Pharmaceutical Company LTD. | 110.45B |
| H.PIO | 98.44B |
| Sam-A Pharm. | 96.01B |
| Ahn-Gook Pharmaceutical | 90.24B |
| Sinsin Pharmaceutical | 86.17B |
| Hwail Pharmaceutical | 85.51B |
| GL Pharm Tech | 84.14B |